Literature DB >> 31191136

A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis.

Maria Catalina Espinosa1, Belicia Ding1, Kati Choi2, Daniel N Cohen3, Marco Marcelli2, Onome Whiteru Ifoeze2.   

Abstract

Frequently used in the management of hypertension and heart failure, hydralazine is associated with the development of adverse rheumatologic side effects. The authors highlight a unique case of drug-induced lupus and drug-induced anti-neutrophil cytoplasmic antibody (ANCA) vasculitis from hydralazine use in a 50-year-old man with sarcoidosis and hypertension.

Entities:  

Keywords:  Drug-induced anti-neutrophil cytoplasmic antibody vasculitis; drug-induced lupus; hydralazine; leukocytoclastic vasculitis

Year:  2019        PMID： 31191136      PMCID： PMC6541081          DOI： 10.1080/08998280.2019.1570422

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  14 in total

1.  Hydralazine-associated cutaneous casculitis presenting with aerodigestive tract involvement.

Authors:  Laura E Levin; Cynthia Magro; James Horowitz; Joanna Harp
Journal:  Cutis       Date:  2017-05

2.  The distinctive histopathology of hydralazine-associated ANCA positive vasculitis: in vivo demonstration of NETosis.

Authors:  Cynthia M Magro; Shabnam Momtahen; Joanna Harp
Journal:  Eur J Dermatol       Date:  2017-02-01       Impact factor: 3.328

3.  Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis.

Authors:  Bharat Kumar; Jennifer Strouse; Melissa Swee; Petar Lenert; Manish Suneja
Journal:  Semin Arthritis Rheum       Date:  2018-01-12       Impact factor: 5.532

4.  Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.

Authors:  Vamsee Priya Marina; Deepak Malhotra; Dinkar Kaw
Journal:  Int Urol Nephrol       Date:  2011-05-17       Impact factor: 2.370

5.  The lupus syndrome induced by hydralazine: a common complication with low dose treatment.

Authors:  H A Cameron; L E Ramsay
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

Review 6.  Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis.

Authors:  Naoto Yokogawa; Frederick B Vivino
Journal:  Mod Rheumatol       Date:  2009-05-08       Impact factor: 3.023

Review 7.  Drug-induced lupus: Traditional and new concepts.

Authors:  Augusto Vaglio; Peter C Grayson; Paride Fenaroli; Davide Gianfreda; Valeria Boccaletti; Gian Marco Ghiggeri; Gabriella Moroni
Journal:  Autoimmun Rev       Date:  2018-07-10       Impact factor: 9.754

8.  Autoantibodies to leucocyte antigens in hydralazine-associated nephritis.

Authors:  G Almroth; S Eneström; J Hed; I Samuelsson; P Sjöström
Journal:  J Intern Med       Date:  1992-01       Impact factor: 8.989

9.  Hydralazine-Induced Vasculitis With Gastrointestinal Pseudomelanosis.

Authors:  Aleksey Novikov; Yi Zhou; Kati Glockenberg; Nikhil A Kumta; Michelle Cohen; Mamta Mehta; David Wan
Journal:  ACG Case Rep J       Date:  2014-10-10

10.  Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report.

Authors:  Justin Keasberry; Jeremy Frazier; Nicole M Isbel; Carolyn L Van Eps; Kimberley Oliver; David W Mudge
Journal:  J Med Case Rep       Date:  2013-01-14
View more
  1 in total

Review 1.  Drug-induced comorbidities in patients with sarcoidosis.

Authors:  Marjolein Drent; Naomi T Jessurun; Petal A Wijnen; Otto Bekers; Aalt Bast
Journal:  Curr Opin Pulm Med       Date:  2022-07-18       Impact factor: 2.868
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.